Chronix closes in on $1.7M for chronic disease diagnosis
Chronix Biomedical, maker of various products used to detect and diagnose chronic diseases, has almost completed its $1.7 million round of equity, according to a filing with the SEC. Based in San Jose, Calif., the company is backed by Pentagram Partners and PrairieGold Venture Partners.
Next Story: Spore Islands launches on Facebook as EA tries social games expansion
Previous Story: Third quarter global game sales decline 6 percent
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.